Kadimastem Debt To Equity vs. Price To Earning
| KDST Stock | ILA 1,189 14.00 1.19% |
For Kadimastem profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Kadimastem to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Kadimastem utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Kadimastem's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Kadimastem over time as well as its relative position and ranking within its peers.
Kadimastem |
Kadimastem Price To Earning vs. Debt To Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Kadimastem's current stock value. Our valuation model uses many indicators to compare Kadimastem value to that of its competitors to determine the firm's financial worth. Kadimastem is currently regarded as number one stock in debt to equity category among its peers. It is rated second overall in price to earning category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Kadimastem by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Kadimastem's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Kadimastem Price To Earning vs. Debt To Equity
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Kadimastem |
| = | 7.80 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Kadimastem |
| = | (167.60) X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Kadimastem Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Kadimastem, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Kadimastem will eventually generate negative long term returns. The profitability progress is the general direction of Kadimastem's change in net profit over the period of time. It can combine multiple indicators of Kadimastem, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. The company was founded in 2008 and is based in Ness Ziona, Israel. KADIMASTEM operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 28 people.
Kadimastem Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Kadimastem. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Kadimastem position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Kadimastem's important profitability drivers and their relationship over time.
Use Kadimastem in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kadimastem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kadimastem will appreciate offsetting losses from the drop in the long position's value.Kadimastem Pair Trading
Kadimastem Pair Trading Analysis
The ability to find closely correlated positions to Kadimastem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kadimastem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kadimastem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kadimastem to buy it.
The correlation of Kadimastem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kadimastem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kadimastem moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kadimastem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Kadimastem position
In addition to having Kadimastem in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Healthcare Thematic Idea Now
Healthcare
Companies that provide healthcare goods and services including hospitals, health maintenance organizations, HMOs, or medical aid manufacturers. The Healthcare theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Kadimastem Stock
To fully project Kadimastem's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Kadimastem at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Kadimastem's income statement, its balance sheet, and the statement of cash flows.